BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 19960786)

  • 1. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis.
    Tiev KP; Coste J; Ziani M; Aubourg F; Cabane J; Dinh-Xuan AT
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):32-8. PubMed ID: 19960786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased alveolar nitric oxide in early systemic sclerosis.
    Wuttge DM; Bozovic G; Hesselstrand R; Aronsson D; Bjermer L; Scheja A; Tufvesson E
    Clin Exp Rheumatol; 2010; 28(5 Suppl 62):S5-9. PubMed ID: 21050538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease.
    Guillen-Del Castillo A; Sánchez-Vidaurre S; Simeón-Aznar CP; Cruz MJ; Fonollosa-Pla V; Muñoz X
    Arch Bronconeumol; 2017 Mar; 53(3):120-127. PubMed ID: 28038794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide.
    Tiev KP; Cabane J; Aubourg F; Kettaneh A; Ziani M; Mouthon L; Duong-Quy S; Fajac I; Guillevin L; Dinh-Xuan AT
    Eur Respir J; 2007 Jul; 30(1):26-30. PubMed ID: 17428812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement.
    Malerba M; Radaeli A; Ragnoli B; Airo' P; Corradi M; Ponticiello A; Zambruni A; Grassi V
    Chest; 2007 Aug; 132(2):575-80. PubMed ID: 17550935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].
    Hua-Huy T; Rivière S; Tiev KP; Dinh-Xuan AT
    Rev Pneumol Clin; 2014 Dec; 70(6):335-42. PubMed ID: 25457218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?
    Guilleminault L; Saint-Hilaire A; Favelle O; Caille A; Boissinot E; Henriet AC; Diot P; Marchand-Adam S
    Respir Med; 2013 Nov; 107(11):1789-96. PubMed ID: 24011803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolar concentration of nitric oxide predicts pulmonary function deterioration in scleroderma.
    Tiev KP; Hua-Huy T; Kettaneh A; Allanore Y; Le-Dong NN; Duong-Quy S; Cabane J; Dinh-Xuan AT
    Thorax; 2012 Feb; 67(2):157-63. PubMed ID: 22026971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the Correlation between HRCT Semi-quantitative Scoring, Concentration of Alveolar Nitric Oxide, and Clinical-functional Parameters of Systemic Sclerosis-induced Interstitial Lung Disease.
    Hoang-Duc H; Pham-Huy Q; Vu-Minh T; Duong-Quy S
    Yale J Biol Med; 2020 Dec; 93(5):657-667. PubMed ID: 33380926
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
    Moore OA; Proudman SM; Goh N; Corte TJ; Rouse H; Hennessy O; Morrisroe K; Thakkar V; Sahhar J; Roddy J; Youssef P; Gabbay E; Nash P; Zochling J; Stevens W; Nikpour M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
    Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
    J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled nitric oxide, but not serum nitrite and nitrate, is a marker of interstitial lung disease in systemic sclerosis.
    Tiev KP; Le-Dong NN; Duong-Quy S; Hua-Huy T; Cabane J; Dinh-Xuan AT
    Nitric Oxide; 2009 May; 20(3):200-6. PubMed ID: 19100854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of interstitial lung disease in systemic sclerosis through partitioning of lung transfer for carbon monoxide.
    Pernot J; Puzenat E; Magy-Bertrand N; Manzoni P; Gondouin A; Bourdin H; Simon-Rigaud ML; Regnard J; Degano B
    Respiration; 2012; 84(6):461-8. PubMed ID: 22301769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease.
    Girgis RE; Gugnani MK; Abrams J; Mayes MD
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1587-91. PubMed ID: 12070057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
    Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease in systemic sclerosis: a simple staging system.
    Goh NS; Desai SR; Veeraraghavan S; Hansell DM; Copley SJ; Maher TM; Corte TJ; Sander CR; Ratoff J; Devaraj A; Bozovic G; Denton CP; Black CM; du Bois RM; Wells AU
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1248-54. PubMed ID: 18369202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension.
    Rolla G; Colagrande P; Scappaticci E; Chiavassa G; Dutto L; Cannizzo S; Bucca C; Morello M; Bergerone S; Bardini D; Zaccagna A; Puiatti P; Fava C; Cortese G
    J Rheumatol; 2000 Jul; 27(7):1693-8. PubMed ID: 10914853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.